I am a Clinical Senior Lecturer at Imperial College, London and the George Institute for Global Health and Consultant in Obstetrics and Gynaecology at Imperial College Healthcare.
My PhD at Imperial College investigated the fetal and maternal inflammatory response in Fetal Growth Restriction. Following this, I won a fellowship with Professor Dame Sally Davies, England CMO, as editor-in-chief of the CMO’s annual report, ‘Women: the health of the 51%.’ As an NIHR Academic Clinical Lecturer I have investigated self-monitoring of maternal cardiovascular health and prevention of Gestational Diabetes.
During the COVID-19 pandemic, I was seconded as clinical adviser to Professor Chris Whitty, England CMO, and produced rapid reviews on coronavirus infection in pregnancy and in children, which I presented to SAGE and formed the basis of clinical guidelines for the UK.
I am co-CI for PAN-COVID, an NIHR-funded global registry of women affected by suspected COVID-19 or confirmed SARS-CoV-2 infection in pregnancy and their neonates.
I am co-CI for COM-SARS-2 study, an historical seroprevalence study in 11,000 maternal serum samples to evaluate the introduction and onset of community transmission of SARs-CoV-2 in NW London. This has led to funding to set up an infection and immunity surveillance platform using these samples and in collaboration with the women who give them.
I lead a new clinical service to introduce post-birth contraception for all women in NW London, to allow women to access reliable family planning before discharge from their maternity service. I am working with colleagues to evaluate this and support national roll-out.
et al., 2022, Remote multimodality monitoring of maternal physiology from the first trimester to postpartum period: study results., Journal of Hypertension, Vol:40, ISSN:0263-6352, Pages:2280-2291
et al., 2022, Current practice in the diagnosis and management of fetal growth restriction: An international survey, Acta Obstetricia Et Gynecologica Scandinavica, ISSN:0001-6349
et al., 2022, Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samples, Plos One, Vol:17, ISSN:1932-6203, Pages:e0273966-e0273966
et al., 2022, Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: A sequential, prospective meta-analysis, American Journal of Obstetrics and Gynecology, ISSN:0002-9378
Womersley K, Hockham C, Mullins E, 2022, The Women's Health Strategy: ambitions need action and accountability., The Bmj, Vol:378, Pages:o2059-o2059